How do animals, plants and even bacteria function without clocks and alarms? We now know this is down to the level of genetics, and humans too have circadian rhythms. But our modern lifetyle is disrupting this, with noticeable consequences. Is there room for innovation to fix the problem? Read here for more….
This September marks the 7th World Alzheimer’s month. In this article, biomarkers for Alzheimer’s are reviewed and we learn more about the innovative game Sea Hero Quest, the crowdsourcing neuroscience project supporting Alzheimer’s research.
For Part II of our event series on the UK-China ecosystem for science and technology development, our speakers presented the emerging area of contract research organizations and also highlighted academic initatives such as OSCAR, a university of Oxford led facility established in Suzhou, China.
SIUOxford hosted an eye-opening two part event focused on the UK-China collaboration ecosystem for science and technology. In Part I, our three invited speakers addressed why there is a good match between the UK and China and presented two examples of start-ups that have benefitted from such collaboration. Read here for more..
Is patent drafting an art form and are patents an underused resource for scientists? What criteria must be satisfied to be granted one? Read here to also learn about pivotal patent cases in biotechnology and the consequences for the patenting culture in this industry.
SIUFrankfurt recently hosted an event to raise awareness of open science. What is open science and how is it relevant to the reproducibility crisis facing academia? How does industry view this topic? Read here to find out more….
In this opinion piece, PhD student Layal Liverpool argues why scientists have the responibility to engage with the public. How is social media influencing genuine science communication and can policy makers be better informed on STEM fields? Read here for more..
We talked to Professor Ted Dinan from the University College Cork to learn more about his field of expertise- gut microbes and how they influence human brain function. Read here for more insights and his advice to medical students thinking about pursuing research.
Almost a century ago, the novel Brave New World portrayed a future in which technology and medicine are integral parts of our lives. How far have we come? How far will we go? This opinion article discusses our advancement in disease diagnostics, with special focus on the interlinks between genome sequencing and machine learning.
At our recent event, SIUOxford raised the question, ‘can computers replace humans in biological research?’ Three experts from academia and industry discussed computational contributions in fields such as disease diagnosis with big data, in silico drug discovery, organ simulation and biocatalyst discovery. Read here to find out more…
Researchers at Stanford University injected two substances into cancerous tumours in mice to eliminate the injected tumour and others of the same cancer type in different parts of the body. The injection also stops cancer from spreading in the body and prevents future tumours that might arise due to genetic conditions. Read this review of the study to learn about the promising results and to understand the key concepts of immunotherapy used in this novel cancer treatment.
By combining the versatility of 3D printing and the diverse metabolic activity of bacteria, a novel method has been developed to make functional living materials. Read on here for an brief summary of a study recently published in Science Advances…
What is the state-of-the-art MR-LINAC and how is it a revolutionary device for radiotherapy treatment? Here, we interview Prof Uwe Oelfke, Head of the Joint Department of Physics at The Institute of Cancer Research (ICR) and The Royal Marsden. He shares his involvement with the MR-LINAC project and his hopes for the future of this technology. Read here for more…
Here we interview Gregg Sando, founder of Cell Medica and Dr. Martin Pule , founder of Autolus. Both recently spoke at the SIULondon event ‘Advances in Immunotherapy’. Read here to find out more about their career journeys into commercialization of immunotherapies and what they see for the future of this field.
The new frontier of the fight against diseases such as cancer is genetic engineering of immune system cells to be better equipped to target disregulated cells. SIULondon recently hosted speakers from Cell Medica, Autolus, GSK and Cell & Gene Therapy Catapult to cover research advances in the field of immunotherapy, hurdles to bringing this treatment to the bedside and regulatory challenges. Check out the event summary here…
SIUOxford recently welcomed Prof Steven Caddick, Head of Innovation at the Wellcome Trust, alongside a panel of PhD and PostDoc speakers. Read the event summary for how Prof Caddick framed the PhD experience and gain insight into how our panelists envision the future of the PhD.
Does the justice system oversee big pharma and its drug patent culture? Who does this culture benefit the most- pharma or the patients? Here is a case study in India where the generic drug manufacturers won against a major pharma company, with many seeing this as a victory for patients in terms of drug afforadability. Read on this opinion piece here…
SIUKatowice recently hosted Prof. Ted Dinan, currently the Professor of Psychiatry and a Principal Investigator in the Alimentary Pharmabiotic Centre at University College Cork. As an expert in intestinal bacteria, he presented recent findings in the field of psychobiotics- illustrating a pronouced connection between gut microbiota and host mental health. Read here to learn more…
SIUOxford recently hosted their first event as part of SIU Career Sessions- a new series addressing different career paths for scientists, e.g. in industry, start-ups, and consulting. We welcomed Dr. Jan Nygaard Jensen from NovoNordisk and Dr. Ita O’Kelly from Immunocore. Read here to learn their invaluable advice for early career researchers thinking about transitioning to industry.
Ahead of the SIULondon ‘Advances in Immunotherapy’ event, we interviewed Dr. Bo Kara from GlaxoSmithKline (GSK) and Dr. Jacqueline Barry from Cell and Gene Therapy (CGT) Catapult. Both experts share their role in supporting the cell and gene therapy field and give their insights on industry science and more… Read on here.